Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.370 GeneticVariation disease BEFREE SNCA mutations cause autosomal dominant parkinsonism and inform our understanding of the molecular underpinnings of synucleinopathies. 30423204 2018
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.400 AlteredExpression disease BEFREE The present findings support the notion that reduced/suppressed LRRK2 expression might delay or prevent motor symptoms and/or frank Parkinsonism in individuals at risk to suffer autosomal dominant Parkinsonism (AD-P) by blocking OS-induced neurodegenerative processes in the DAergic neurons. 28041945 2017
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.370 Biomarker disease CTD_human Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions. 27324791 2017
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.370 Biomarker disease CTD_human Protective effect of Geraniol on the transgenic Drosophila model of Parkinson's disease. 27026137 2016
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.400 Biomarker disease BEFREE In the period since LRRK2 (leucine-rich repeat kinase 2) was identified as a causal gene for late-onset autosomal dominant parkinsonism, a great deal of work has been aimed at understanding whether the LRRK2 protein might be a druggable target for Parkinson's disease (PD). 26811536 2016
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.400 GeneticVariation disease BEFREE Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant Parkinsonism with pleomorphic pathology including deposits of aggregated protein and neuronal degeneration. 26744328 2016
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.370 Biomarker disease CTD_human Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism. 26687234 2016
Entrez Id: 5368
Gene Symbol: PNOC
PNOC
0.300 Biomarker disease CTD_human Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism. 26687234 2016
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.400 Biomarker disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.370 Biomarker disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.300 Therapeutic disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 27429
Gene Symbol: HTRA2
HTRA2
0.300 Biomarker disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.300 Biomarker disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 11315
Gene Symbol: PARK7
PARK7
0.300 Biomarker disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 65018
Gene Symbol: PINK1
PINK1
0.300 Biomarker disease CTD_human Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. 26558463 2015
Entrez Id: 55532
Gene Symbol: SLC30A10
SLC30A10
0.300 Biomarker disease CTD_human Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence. 26220508 2015
Entrez Id: 6622
Gene Symbol: SNCA
SNCA
0.370 Biomarker disease CTD_human shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. 26075822 2015
Entrez Id: 2629
Gene Symbol: GBA
GBA
0.300 Biomarker disease CTD_human Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies. 25881142 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.300 Therapeutic disease CTD_human A recurrent mutation in PARK2 is associated with familial lung cancer. 25640678 2015
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.300 Biomarker disease CTD_human A recurrent mutation in PARK2 is associated with familial lung cancer. 25640678 2015
Entrez Id: 216
Gene Symbol: ALDH1A1
ALDH1A1
0.300 Biomarker disease CTD_human Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease. 25045800 2014
Entrez Id: 8854
Gene Symbol: ALDH1A2
ALDH1A2
0.300 Biomarker disease CTD_human Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease. 25045800 2014
Entrez Id: 120892
Gene Symbol: LRRK2
LRRK2
0.400 Biomarker disease CTD_human G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy. 25017139 2014
Entrez Id: 65018
Gene Symbol: PINK1
PINK1
0.300 Biomarker disease CTD_human Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells. 24792327 2014
Entrez Id: 1981
Gene Symbol: EIF4G1
EIF4G1
0.010 GeneticVariation disease BEFREE Pathogenic mutations in the EIF4G1 gene were recently reported as a cause of autosomal dominant parkinsonism. 24704100 2014